Multiple Myeloma News
Myeloma-bone marrow adipocyte axis in tumour survival and treatment response
Source: Myeloma : nature.com subject feeds Read More
Top Myeloma Journal Articles for the Week of June 14, 2021
Here are the top 10 journal articles from the week of June 14, 2021 as selected by the MYELOMA360 staff. Real-world analysis of patient characteristics, treatment outcomes, and healthcare resource utilization across Europe in patients with newly diagnosed multiple...
Off-the-shelf immune drug shows promise in aggressive multiple myeloma
Source: Multiple Myeloma News -- ScienceDaily A subcutaneous injection of the immune-boosting drug teclistamab was found to be safe and elicit responses in a majority of patients with relapsed or refractory multiple myeloma. Read More
Treating COVID-19 in a patient with multiple myeloma
Source: Multiple Myeloma News -- ScienceDaily A case study of a patient in Wuhan, China, suggests that the immunosuppressant tocilizumab may be an effective COVID-19 treatment for very ill patients who also have multiple myeloma and other blood cancers. The report...
New technology helps in hunt for new cancer drug combinations
Source: Multiple Myeloma News -- ScienceDaily A revolutionary new technology has been applied to reveal the inner workings of individual cancer cells - potentially identifying more effective treatment combinations for people with cancer. Read More
Lenalidomide may delay onset of myeloma-related bone, organ damage
Source: Multiple Myeloma News -- ScienceDaily The largest randomized trial in asymptomatic patients with smoldering multiple myeloma suggests that lenalidomide, a cancer drug, may delay the onset of bone and other myeloma-related organ damage. Read More
Unprecedented therapy found effective for blood cancer patients with no treatment options
Source: Multiple Myeloma News -- ScienceDaily Researchers have found a new type of therapy to be effective for patients with a particular type of bone marrow cancer that is resistant to several standard therapies. Read More
New epigenetic regulatory mechanisms involved in multiple myeloma growth
Source: Multiple Myeloma News -- ScienceDaily An international team of researchers has analyzed the function of the histone demethylase KDM5A in multiple myeloma, one of the three major hematological cancers, and clarified the mechanism by which it promotes myeloma...
Personalized cancer vaccine deemed safe, shows potential benefit against cancer
Source: Multiple Myeloma News -- ScienceDaily A personalized cancer vaccine raised no safety concerns and showed potential benefit in patients with different cancers, including lung and bladder, that have a high risk of recurrence, according to results from an...
New CAR T-Cell therapy extends remission in heavily relapsed multiple myeloma patients
Source: Multiple Myeloma News -- ScienceDaily A new type of CAR T-cell therapy more than triples the expected length of remission for multiple myeloma patients who have relapsed several times, according to an international clinical trial. Read More